MMJ PhytoTech Limited (ASX:MMJ) is pleased to advise that the Canadian Federal Government has confirmed it will move to legalise the recreational cannabis market by 1 July 2018. The Federal Government's initial plans and proposed legislative framework are expected to be publically released on 10 April 2017.
MMJ PhytoTech Limited (ASX:MMJ) is pleased to advise that the Company's Australian distribution partner, HL Pharma Pty Ltd, has received approval for a medicinal cannabis importation licence from the Department of Health.
Stemcell United Ltd (ASX:SCU) is pleased to announce the appointment of Medicinal Cannabis expert Mr. Nevil Schoenmakers as a Strategic Advisor to the Board to assist the Company assess opportunities in the medicinal cannabis sector.
MMJ PhytoTech Ltd (ASX:MMJ) is pleased to provide the following sales and operations update on its wholly-owned Switzerland-based subsidiary, Satipharm AG.
MMJ PhytoTech Limited (ASX:MMJ) is pleased to advise that its wholly-owned subsidiary United Greeneries Holdings Ltd has executed an agreement with Cowichan Tribes in respect to the leasing of a 13-acre land package located adjacent to the Company's existing Duncan Facility.
Rhinomed (ASX:RNO) is pleased to provide an update on the expansion of its global distribution program. The company can report that Rhinomed has been added as a vendor by two major US based pharmacy wholesalers and the successful expansion of the listing of its Mute Sleep technology by Symbion in Australia.
The directors present their report, together with the financial statements, on the consolidated entity consisting of MMJ PhytoTech Limited (ASX:MMJ) and the entities it controlled at the end of, or during, the half-year ended 31 December 2016.
